Summary

Animal models remain indispensable for evaluating the safety profile of novel chemicals, pharmaceuticals and environmental agents before clinical or commercial use. These studies typically encompass acute, sub-chronic and chronic exposures in rodents or other species, integrating behavioural, clinical and pathological endpoints to characterise systemic, organ-specific and genetic damage. Key parameters include determination of lethal dose thresholds (LD50), identification of no-observed-adverse-effect levels (NOAEL) and lowest-observed-adverse-effect levels (LOAEL). Modern approaches increasingly combine traditional histopathology with molecular assays—such as the comet assay for DNA strand breaks and high-throughput omics—to refine detection of subtle toxic responses. Ethical considerations and regulatory frameworks drive the adoption of study designs that minimise animal use while maximising data quality. Globally, such assessments underpin regulatory decisions for drug approval, industrial chemical management and environmental risk evaluation, with growing emphasis on translational validity, interspecies scaling and replacement strategies including in vitro and in silico models.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Toxicity Assessment in Animal Models publication trend

The graph below shows the total number of articles in toxicity assessment in animal models across all publications each year (not limited to Nature Index journals).

Technical terms

LD50: The dose at which 50% of test animals die following exposure.

NOAEL: The highest dose at which no adverse effects are observed.

LOAEL: The lowest dose at which adverse effects become evident.

Genotoxicity: The capacity of a substance to damage genetic information in cells.

Comet assay: A technique using single-cell gel electrophoresis to detect DNA strand breaks.

References

  1. General toxicity and genotoxicity studies of a new scale inhibitor for seawater desalination. Environmental Sciences Europe (2023).
  2. The Toxicological and Pharmacological Evaluation of the Anacyclus pyrethrum Aqueous Extract: Implications for Medicinal and Therapeutic Applications. Stresses (2024).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.